Clinical trial
Attenuation of the Hemodynamic Response to Double-lumen Endotracheal Intubation With Nebulized Lidocaine: a Randomized, Double-blind, Controlled Trial
NCT05850702 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Attenuation of the Hemodynamic Response to Double-lumen Endotracheal Intubation With Nebulized Lidocaine: a Randomized, Double-blind, Controlled Trial
- Lead sponsor
- RenJi Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- June 15, 2023
- Completion date
- September 9, 2025
- Enrollment
- 92 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.